However, ACADL expression had no significant difference between StageI and StageIII/IV (P > 0.05), suggesting ACADL may play a certain protective role in the early progression (from StageII to StageI) of NSCLC (Fig. 1c). Here, ACADL is linked to non-small cell lung carcinoma.